(1) Hypertransfusion therapy to block production of defective cells, e.g., thalassemia, sickle cell anemia; (2) exchange transfusionhemolytic disease of newborn, sickle cell crisis; (3) transplant recipientsdecreases rejection of cadaveric kidney transplants.
Section 1. Care of the Hospitalized Patient